Entrada Therapeutics Inc. (TRDA)
13.19
0.01 (0.08%)
At close: Jan 28, 2025, 1:45 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | 129.01M | n/a | n/a | n/a | n/a |
| Cost of Revenue | 99.88M | 1.90M | 1.12M | 326.00K | 104.00K |
| Gross Profit | 29.13M | -1.90M | -1.12M | -326.00K | -104.00K |
| Operating Income | -3.16M | -97.25M | -51.13M | -26.67M | -11.82M |
| Interest Income | 15.22M | 2.63M | n/a | 144.00K | 451.00K |
| Pretax Income | 12.06M | -94.62M | -51.16M | -26.52M | -5.10M |
| Net Income | -6.68M | -87.46M | -50.07M | -26.38M | -4.65M |
| Selling & General & Admin | 32.29M | 30.64M | 15.20M | 5.57M | 3.61M |
| Research & Development | 99.88M | 66.61M | 35.93M | 21.10M | 8.22M |
| Other Expenses | n/a | n/a | n/a | n/a | 6.27M |
| Operating Expenses | 132.18M | 97.25M | 51.13M | 26.67M | 11.82M |
| Interest Expense | n/a | 2.63M | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 132.18M | 97.25M | 51.13M | 26.67M | 11.82M |
| Income Tax | 18.74M | -7.16M | -1.09M | -144.00K | -451.00K |
| Shares Outstanding (Basic) | 33.05M | 31.29M | 31.22M | 31.25M | 31.25M |
| Shares Outstanding (Diluted) | 33.05M | 31.29M | 31.22M | 31.25M | 31.25M |
| EPS (Basic) | -0.2 | -2.79 | -1.6 | -0.84 | -0.15 |
| EPS (Diluted) | -0.2 | -2.79 | -1.6 | -0.84 | -0.15 |
| EBITDA | -321.00K | -95.35M | -50.01M | -26.34M | -11.72M |
| Depreciation & Amortization | 2.84M | 1.90M | 1.12M | 326.00K | 104.00K |